{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,24]],"date-time":"2026-04-24T03:52:51Z","timestamp":1777002771851,"version":"3.51.4"},"reference-count":28,"publisher":"Informa UK Limited","issue":"2","license":[{"start":{"date-parts":[[2023,12,10]],"date-time":"2023-12-10T00:00:00Z","timestamp":1702166400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Annals of Medicine"],"published-print":{"date-parts":[[2023,12,12]]},"DOI":"10.1080\/07853890.2023.2264850","type":"journal-article","created":{"date-parts":[[2023,12,10]],"date-time":"2023-12-10T14:48:31Z","timestamp":1702219711000},"update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":8,"title":["Safety, tolerability, pharmacokinetics and pharmacodynamics of a novel farnesoid X receptor (FXR) agonist-TQA3526 in healthy Chinese volunteers: a double-blind, randomized, placebo-controlled, dose-escalation, food effect phase I study"],"prefix":"10.1080","volume":"55","author":[{"given":"Jia","family":"Xu","sequence":"first","affiliation":[{"name":"Phase I Clinical Trial Unit, First Hospital, Jilin University, Changchun, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hong","family":"Zhang","sequence":"additional","affiliation":[{"name":"Phase I Clinical Trial Unit, First Hospital, Jilin University, Changchun, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hong","family":"Chen","sequence":"additional","affiliation":[{"name":"Phase I Clinical Trial Unit, First Hospital, Jilin University, Changchun, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaoxue","family":"Zhu","sequence":"additional","affiliation":[{"name":"Phase I Clinical Trial Unit, First Hospital, Jilin University, Changchun, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Haiyan","family":"Jia","sequence":"additional","affiliation":[{"name":"Phase I Clinical Trial Unit, First Hospital, Jilin University, Changchun, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhongnan","family":"Xu","sequence":"additional","affiliation":[{"name":"Chia Tai Tianqing Pharmaceutical Group Co. Ltd., Nanjing, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dandan","family":"Huo","sequence":"additional","affiliation":[{"name":"Chia Tai Tianqing Pharmaceutical Group Co. Ltd., Nanjing, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hong","family":"Zhang","sequence":"additional","affiliation":[{"name":"Chia Tai Tianqing Pharmaceutical Group Co. Ltd., Nanjing, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cuiyun","family":"Li","sequence":"additional","affiliation":[{"name":"Phase I Clinical Trial Unit, First Hospital, Jilin University, Changchun, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yanhua","family":"Ding","sequence":"additional","affiliation":[{"name":"Phase I Clinical Trial Unit, First Hospital, Jilin University, Changchun, China"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"301","published-online":{"date-parts":[[2023,12,10]]},"reference":[{"key":"e_1_3_5_2_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbalip.2019.07.006"},{"key":"e_1_3_5_3_1","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2014.11.039"},{"key":"e_1_3_5_4_1","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2017.01.003"},{"key":"e_1_3_5_5_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2018.05.036"},{"key":"e_1_3_5_6_1","doi-asserted-by":"publisher","DOI":"10.1007\/s10620-016-4124-3"},{"key":"e_1_3_5_7_1","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.v20.i42.15539"},{"key":"e_1_3_5_8_1","unstructured":"European Medicines Agency. Reflection paper on regulatory requirements for the development of medicinal products for chronic non-infections liver disease (PBC PSC NASH); [cited 2018 Nov 26]. https:\/\/www.ema.europa.eu\/documents\/scientific-guideline\/reflection-paper-regulatory-requirements-development-medicinal-products-chronic-non-infectious-liver_en.pdf"},{"key":"e_1_3_5_9_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2009.03.007"},{"key":"e_1_3_5_10_1","unstructured":"National Institute of Diabetes and Digestive and Kidney Diseases. Symptoms and causes of NAFLD and NASH; 2016 [cited 2018 Oct 12]. https:\/\/www.niddk.nih.gov\/health-information\/liver-disease\/nafld-nash\/symptoms-causes"},{"key":"e_1_3_5_11_1","doi-asserted-by":"publisher","DOI":"10.2478\/jomb-2014-0049"},{"key":"e_1_3_5_12_1","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2012.04.001"},{"key":"e_1_3_5_13_1","doi-asserted-by":"publisher","DOI":"10.1111\/hepr.12511"},{"key":"e_1_3_5_14_1","doi-asserted-by":"publisher","DOI":"10.1159\/000443344"},{"key":"e_1_3_5_15_1","doi-asserted-by":"publisher","DOI":"10.2741\/4892"},{"key":"e_1_3_5_16_1","doi-asserted-by":"publisher","DOI":"10.1038\/nrgastro.2013.193"},{"key":"e_1_3_5_17_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2008.864"},{"key":"e_1_3_5_18_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.c5702"},{"key":"e_1_3_5_19_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.298.10.1180"},{"key":"e_1_3_5_20_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.cmet.2012.04.004"},{"key":"e_1_3_5_21_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.cgh.2021.07.020"},{"key":"e_1_3_5_22_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2019.10.006"},{"key":"e_1_3_5_23_1","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2014.08.029"},{"key":"e_1_3_5_24_1","doi-asserted-by":"publisher","DOI":"10.1002\/hep.29569"},{"key":"e_1_3_5_25_1","doi-asserted-by":"publisher","DOI":"10.1208\/s12248-011-9306-5"},{"key":"e_1_3_5_26_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1509840"},{"key":"e_1_3_5_27_1","doi-asserted-by":"publisher","DOI":"10.1172\/JCI64551"},{"key":"e_1_3_5_28_1","doi-asserted-by":"publisher","DOI":"10.1194\/jlr.M001602"},{"key":"e_1_3_5_29_1","doi-asserted-by":"publisher","DOI":"10.1111\/dom.12681"}],"container-title":["Annals of Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/07853890.2023.2264850","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,20]],"date-time":"2024-02-20T12:08:35Z","timestamp":1708430915000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/07853890.2023.2264850"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,12,10]]},"references-count":28,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2023,12,12]]}},"alternative-id":["10.1080\/07853890.2023.2264850"],"URL":"https:\/\/doi.org\/10.1080\/07853890.2023.2264850","relation":{},"ISSN":["0785-3890","1365-2060"],"issn-type":[{"value":"0785-3890","type":"print"},{"value":"1365-2060","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,12,10]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=iann20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=iann20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2023-06-08","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-09-25","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-12-10","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}],"article-number":"2264850"}}